Tizanidine Hydrochloride Capsule
Product Images NDC 71335-2872

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 71335-2872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352872)

Label for tizanidine hydrochloride 6 mg capsules, a human prescription drug. The label shows the NDC 71335-2872-1 and includes capsule count of 30. It is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Rubicon Research Private Limited. The label highlights storage instructions, dispensing in light-resistant containers, and warnings about drowsiness and keeping out of reach of children.*

FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules Figure 1)

A line graph depicting plasma tizanidine concentration (ng/mL) over time (hours) following dosing. It compares four conditions: 2 x 4 mg tizanidine tablets with food, without food; and 2 x 4 mg tizanidine capsules with food, without food, tracking concentration changes up to 24 hours post-dose.*

FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules Figure 2)

A line graph depicting the improvement in Ashworth Score over time for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The x-axis represents hours post-dose from 0 to 6, and the y-axis measures the improvement score from 1 to -5, with error bars shown for each data point.*

FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules Figure 3)

A line graph comparing improvement in Ashworth Score over three study phases: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Two groups are shown: tizanidine (mean dose 28.8 mg) and placebo, with mean scores and error bars.*

FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules Structure)

Chemical structure of tizanidine hydrochloride. The diagram shows the molecular arrangement including a chlorinated benzene ring fused with a thiazole ring, an attached imidazoline ring, and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.